PROCTER & GAMBLE HEALTH L DCF Valuation

PGHL · Healthcare · Current price ₹6,799.5

Full stock page
DocStoX fair value
₹1,846
low confidence
Intrinsic-value estimate
₹687
44% ROE fading to 12% over ~10 yrs, on ₹316 book
Current price
₹6,800
Economic moat
Narrow
Medium uncertainty
5Y profit growth
+13.1%
Model it yourself — DCF Calculator
Opens pre-filled with PROCTER & GAMBLE HEALTH L's latest numbers.

PROCTER & GAMBLE HEALTH L intrinsic-value estimate

Our intrinsic-value model estimates PROCTER & GAMBLE HEALTH L is worth ₹687 per share, based on 44% ROE fading to 12% over ~10 yrs, on ₹316 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A narrow economic moat sets how long that edge is assumed to last.

Try your own assumptions

Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills PROCTER & GAMBLE HEALTH L's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.

More on PROCTER & GAMBLE HEALTH L

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.